Bionano Genomics, Inc.
BNGO
$1.18
-$0.02-1.67%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 8.17M | 6.69M | 7.95M | 7.37M | 6.73M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 8.17M | 6.69M | 7.95M | 7.37M | 6.73M |
| Cost of Revenue | 3.86M | 3.44M | 4.55M | 4.00M | 3.26M |
| Gross Profit | 4.31M | 3.25M | 3.40M | 3.37M | 3.48M |
| SG&A Expenses | 8.54M | 8.01M | 8.71M | 9.06M | 8.35M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 15.39M | 14.58M | 16.49M | 15.91M | 14.53M |
| Operating Income | -7.22M | -7.90M | -8.54M | -8.54M | -7.80M |
| Income Before Tax | -7.42M | -8.29M | -7.90M | -8.49M | -6.85M |
| Income Tax Expenses | 7.00K | 10.00K | 35.00K | 14.00K | 10.00K |
| Earnings from Continuing Operations | -7.42M | -8.30M | -7.93M | -8.50M | -6.86M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -7.42M | -8.30M | -7.93M | -8.50M | -6.86M |
| EBIT | -7.22M | -7.90M | -8.54M | -8.54M | -7.80M |
| EBITDA | -4.87M | -5.54M | -6.35M | -6.11M | -5.37M |
| EPS Basic | -0.64 | -0.76 | -0.77 | -1.59 | -1.99 |
| Normalized Basic EPS | -0.40 | -0.47 | -0.48 | -0.99 | -1.24 |
| EPS Diluted | -0.64 | -0.76 | -0.77 | -1.59 | -1.99 |
| Normalized Diluted EPS | -0.40 | -0.47 | -0.48 | -0.99 | -1.24 |
| Average Basic Shares Outstanding | 11.55M | 10.98M | 10.29M | 5.34M | 3.44M |
| Average Diluted Shares Outstanding | 11.55M | 10.98M | 10.29M | 5.34M | 3.44M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |